Insider filing · CRNX
Matthew K Fust
Director
profile →
Crinetics Pharmaceuticals, Inc.
CRNX · Healthcare · 33 filings in 24 months
ticker →
Matthew K Fust sold $716K of Crinetics Pharmaceuticals (CRNX)
Executed Sep 26 2025, disclosed Sep 30 2025, 4 days later.
Value, as filed
$716K
16,000 sh × $44.75
Executed
Sep 26 2025
the trade date, as filed
Disclosed
Sep 30 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MFMatthew K Fust (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Crinetics Pharmaceuticals, Inc. (CRNX). The largest single filing was $716K of CRNX (16,000 sh × $44.75, as filed), executed Sep 26 2025.
The name
CRNXHealthcare · Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of n…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→